Cholesterol became the cause of heart attacks because a profitable story won a scientific argument in the 1960s, and the drugs that move the number arrived later to keep the story alive. A Midwestern Doctor's October 2026 essay, "The Great Cholesterol Lie and the Dangers of Statins," is one long attempt to separate the molecule from the myth.
The first myth is that we settled the cause of heart disease by looking at the evidence. In the 1960s and 1970s John Yudkin argued that the sugar being poured into processed food was the chief culprit. Ancel Keys argued it was saturated fat and cholesterol, and he won. His Seven Countries Study drew a clean line: more saturated fat, more heart disease. The line depended on the countries. Italy, Greece, Yugoslavia, the Netherlands, Finland, the United States, and Japan produced it. Finland, Israel, the Netherlands, Germany, Switzerland, France, and Sweden would have produced the opposite. Keys became nutritional dogma anyway. In 2016, a historical analysis published in JAMA Internal Medicine revealed that the sugar industry actively subverted public health research to protect its commercial interests. Internal documents showed that in 1965, the Sugar Research Foundation paid Harvard scientists to publish a literature review in the New England Journal of Medicine that intentionally downplayed the link between sucrose and heart disease, while pointing the primary blame at dietary fat and cholesterol. This orchestrated campaign directly targeted the work of British nutritionist John Yudkin, who had long warned of sugar's metabolic dangers. By successfully discrediting Yudkin's findings and suppressing the sugar hypothesis, the industry cast his work as fringe science and successfully steered global dietary guidelines toward low-fat, high-sugar recommendations for decades. Guidelines still read as if Keys had been right and the bribe had never happened.
The second myth is that lowering cholesterol saves lives. It lowers a number. That is not the same thing. A randomised trial Keys himself led, of 9,423 adults in mental hospitals and a nursing home whose diets could actually be controlled, replaced half their animal fat with vegetable oil. Cholesterol fell. For every 30-point drop, the risk of death rose by 22 percent. The study was not published. A recovered Australian trial from the same era found that swapping some saturated fat for vegetable oil raised the risk of dying by 17.6 percent. It was not published either. A Lancet follow-up of older adults found that each 1 mmol/L increase in total cholesterol corresponded to a 15 percent decrease in mortality. A 2025 systematic review found no statistically significant benefit from cutting saturated fat and concluded it cannot currently be recommended to prevent cardiovascular disease or death. In diabetics the liver turns excess sugar into fat and then makes cholesterol to move that fat. The cholesterol is the shipping label. The sugar is the cargo.
The third myth is the plaque itself. The industry model says cholesterol seeps into the artery wall and slowly chokes it. The buried alternative, which the essay prefers, says the artery is injured first, the body lays down a clot to heal it, and the healed clot becomes the atherosclerotic lesion. Cholesterol is in the lesion because it is in the clot and in the repair, not because it was the match. That model explains why so many people with "high" cholesterol never have a heart attack, and why so many with "normal" cholesterol do. It also explains why a drug that only changes the shipping label does so little to the underlying damage: smoking, sugar, insulin, pressure, and the inflammatory injury to the vessel wall.
The fourth myth is that statins are the answer because they move the number. Before they existed, cholesterol was hard to lower, and the thresholds were higher. Once the drugs worked on a lab value, the dangerous level was revised downward and the eligible population was revised upward. In 2008–09, 12 percent of Americans over 40 reported taking a statin. By 2018–19 it was 35 percent. Nearly a trillion dollars has been spent on them. Independent researchers looking at the published trials, which are the ones most likely to flatter the drugs, found that five years of daily use bought about three or four extra days of life, and that even this scrap showed up in men. A 2026 meta-analysis of the ten randomised trials that enrolled only people with no prior heart, vascular, or cerebrovascular disease, 85,829 participants, found cholesterol-lowering drugs, mostly statins, did not reduce death. Both groups died at 3.9 percent. The mortality benefit reported by the industry's own trial collaboration came from pooling those healthy people with patients who already had heart disease. The raw data from that collaboration are still not released to outside researchers.
The harms are not subtle, and they are not imaginary. Statins block an early step in a pathway the body uses for more than cholesterol. Muscle pain, fatigue on exertion, nerve injury, liver injury, new diabetes, and cognitive trouble are the common receipts. The essay's figure is that roughly one patient in five is injured in some recognizable way. When those patients stop the drug, they are reclassified as "statin intolerant," and a newer patented cholesterol drug is approved for the same purpose: lowering the number. The market survives the failure of the first product by selling a second product to the people the first one hurt.
None of this is a dare to throw away a prescription after a heart attack. Secondary prevention is a different ledger from putting a healthy 55-year-old on a pill because a guideline moved. The myth is the leap from "this number can be lowered" to "this number is the disease." Cholesterol is a structural molecule and a transport molecule. Heart disease is injured artery, clot, and repair. The diet advice that followed Keys traded one industry's product for another's, buried the trials that came out the wrong way, and built a pharmacy around a lab slip. The bill is still being paid in muscle, in blood sugar, and in days of life that were never there.
https://www.midwesterndoctor.com/p/the-great-cholesterol-lie-and-the